에 대한 최신 뉴스 Tilray Brands (NASDAQ:TLRY) 주식

Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Meta Platforms Inc.

News

Legal

Markets

Tech

Media

BABA

NVDA

TLRY

메타 플랫폼스(NASDAQ:META)는 케임브리지 애널리티카(Cambridge Analytica)의 데이터 스캔들에 대한 미국 대법원의 항소가 기각된 후 수십억 달러 규모의 소송에 직면할 예정이다.

메타, 대법원이 CA 데이터 스캔들에 대한 항소를 기각하여 수십억 달러 규모의 소송 직면

Screen Shot 2024-07-29 at 3.27.35 PM

Cannabis

Earnings

Movers

틸레이 브랜즈(NASDAQ:TLRY)는 월요일 시장 마감 후 2024 회계연도 4분기 재무 결과를 발표했다. 이번 분기의 주요 지표를 살펴보세요.

틸레이: 4분기 매출 및 EPS 예상 상회에 주가 급등, 대마초, 음료 및 웰빙의 융합을 선도

Tilray Brands Inc

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF">Australis Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed up 29900.00% at $0.0003</li>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed up 5400.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 316.67% at $0.0005</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 56.36% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.89% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 8.97% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 8.11% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 4.52% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 3.99% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.58% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 3.36% at $1.21</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 3.05% at $5.40</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 52.94% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 50.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 10.10% at $0.89</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 9.76% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 9.48% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 8.00% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 7.66% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 7.58% at $1.21</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 7.26% at $1.66</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 6.25% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 5.38% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.02% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed down 3.78% at $57.31</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 3.72% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 3.23% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUSAF

BMMJ

CBDY

CNGGF

CNTMF

CVSI

CWBHF

CXXIF

ELLXF

FFNTF

FUAPF

GNLN

GTBIF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

MRMD

OILFF

RMHB

RSSFF

SOLCF

TGIFF

YCBD

Cannabis Stock Gainers And Losers From June 2, 2025

<a href="https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/" title="https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/">https://www.marijuanamoment.net/trump-wants-to-delete-state-medical-marijuana-protections-from-budget-while-continuing-to-block-cannabis-sales-legalization-in-d-c/</a>

Biotech

General

AKAN

CRON

GRWG

IMCC

MAPS

MSOS

SNDL

'Trump Wants To Delete State Medical Marijuana Protections From Budget While Continuing To Block Cannabis Sales Legalization In D.C.' - Marijuana Moment

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 22.08% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 19.73% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 13.64% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 9.67% at $0.48</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 6.06% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 5.77% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.14% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 3.54% at $7.42</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.25% at $0.28</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 50.00% at $0.0002</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 22.81% at $1.32</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 11.29% at $0.60</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 8.49% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 7.15% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 5.88% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.36% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 3.27% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 3.08% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.07% at $4.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLSH

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

ITHUF

NWVCF

TCNNF

ZDPY

Marijuana Stock Movers For May 30, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 36.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 16.87% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 13.70% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 10.56% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 7.02% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 4.76% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 3.26% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 3.20% at $0.77</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 3.09% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 3.08% at $0.00</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 45.76% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 20.00% at $0.0004</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 8.65% at $1.69</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.35% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.35% at $0.44</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLOZF

CNBX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

MGWFF

XXII

Cannabis Stock Gainers And Losers From May 29, 2025

Germany imported a record 37.2 tons of medical cannabis in the first quarter of 2025, marking a 4.6x increase compared to the same period last year, <a href="https://www.bfarm.de/DE/Bundesopiumstelle/_FAQ/Medizinisches-Cannabis/MedCan-Einfuhr-Ausfuhr/faq-liste.html">according</a> to the Federal Institute for Drugs and Medical Devices (BfArM). Per publicly available data, the country is now the largest importer of legal medical cannabis in the world, yet looming regulatory headwinds are already taking shape.
<h2 class="wp-block-heading">German Market Sets A New Benchmark</h2>
The Q1 2025 import surge, which includes dried flower and extracts (converted to flower equivalents), builds on momentum following Germany's April 2024 medical cannabis reform under the Cannabis Act (MedCanG). The previous quarterly record was 32.1 tons in Q4 2024.
"The latest quarterly figures for cannabis imports send a clear message: we are on track for 150 tons of cannabis to be imported into Germany for medical and scientific purposes by 2025. As of today, Germany is likely already the largest medical cannabis market in the world," said Niklas Kouparanis, CEO and co-founder of Bloomwell Group, one of Germany's leading cannabis platforms.
"The main reason for this remarkable progress is low-threshold digital access. This has enabled several hundred thousand patients, who previously obtained medical cannabis illegally (which involved considerable risks), to access legal medical cannabis prescribed by physicians and dispensed in licensed pharmacies," he continued.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-e500m-2500-pharmacies-now-dispense-211-grow-clubs-approved">Germany&#8217;s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved</a>
Based on the latest research from Zuanic &amp; Associates, Germany's actual pharmacy purchases in Q1 2025 are estimated at 22.3 tons. If fewer imports were rejected or re-exported than in previous years, real domestic consumption could be as high as 28 tons.
At an estimated retail price of €8 per gram, this puts Germany's medical cannabis market at an annual run-rate of €714 to €900 million, or roughly $770 million to $970 million.
<h2 class="wp-block-heading">Who&#8217;s Supplying The Boom?</h2>
Canada continues to be the top source, responsible for 43% of all German imports in Q1 2025, followed by Portugal (32%) and Denmark (7%). However, analysts point out that much of Portugal's share consists of Canadian cannabis processed under EU-GMP guidelines before re-export to Germany.
This benefits several Canadian licensed producers, including:
<ul class="wp-block-list">
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), which reported $13.9 million in international medical cannabis sales in its latest quarter</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>), which shipped C$26.3 million worth of cannabis to Europe in the December quarter, according to estimates from Zuanic &amp; Associates.</li>
<li>Village Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>), which reported a 3.8x year-over-year increase in medical cannabis exports, per Zuanic &amp; Associates.</li>
<li>Organigram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>), with approximately 80% growth year-over-year in medical cannabis exports, according to Zuanic &amp; Associates.</li>
<li>Avant Brands (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AVTBF#OTC">AVTBF</a>), which reported C$4.7 million in medical cannabis exports in Q1, per Zuanic &amp; Associates.</li>
</ul>
Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) also plays a major role through its stake in Four20 Pharma, one of Germany's top importers. It has built a global supply chain that includes facilities in Canada, Portugal, the UK, and Poland.
<h2 class="wp-block-heading">Political Risks On The Horizon</h2>
Despite strong fundamentals, the market's long-term stability may be challenged by Germany's new CDU-led coalition. Federal Health Minister Nina Warken has called the growth in medical cannabis use "disturbing" and raised concerns about what she describes as "too easy access."
"With the new government set to review the Cannabis Act rules by the fall, the industry has time to lobby," wrote Pablo Zuanic of Zuanic &amp; Associates, "but restrictions on telehealth are likely, in our view."
Germany's low-barrier digital access is widely credited with accelerating patient uptake, particularly among individuals previously relying on the illicit market. Any changes to telemedicine regulations could have broad implications.
<h2 class="wp-block-heading">There&#8217;s Still Room To Grow</h2>
Even with 37.2 tons of cannabis imported in Q1, Zuanic notes that population penetration remains low—only 0.4% to 0.5% of Germans currently access medical cannabis, compared to 3% to 4% in many U.S. states with mature MMJ programs.
"The German model serves as a model for the entire EU in how to ensure safe, reliable, and digitally-powered access to medical cannabis," Kouparanis said. "There is no turning back."
<h2 class="wp-block-heading">Learn More At Benzinga&#8217;s Cannabis Capital Conference In Chicago</h2>
As Germany&#8217;s market evolves, the implications for global operators and investors will be explored in detail at the <a href="https://www.benzinga.com/cannabis-conference">Benzinga Cannabis Capital Conference</a>, which will take place June 9–10 in Chicago.
Panel: Cracking the German Market: Navigating Cannabis Opportunities Amid Political Change
Speakers:
<ul class="wp-block-list">
<li>Michael Sassano, CEO, Somai Pharmaceuticals</li>
<li>Albert Schwarzmeier, CEO, enua</li>
<li>Chanda Macias, CEO, Women Grow / National Holistic</li>
<li>Constantin von der Groeben, Managing Director, Demecan</li>
<li>Moderator: Jamie Pearson, CEO, New Holland Group</li>
</ul>
Tickets available <a href="https://www.benzinga.com/cannabis-conference">here</a>.
Photo: Shutterstock

Eurozone

AVNT

AVTBF

Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting

From Texas&#8217; escalating war on hemp to EU-certified inhalers and Argentina&#8217;s full-scale overhaul of its medical cannabis program, this week offered no shortage of headlines that could shape the future of the cannabis industry across borders and sectors.
Let&#8217;s dig in. 
<h3 class="wp-block-heading">Policy &amp; Legal</h3>
Texas House Passes Hemp Ban, Threatens 50,000 Jobs
In a late-night vote Wednesday, the Texas House passed SB 3, banning hemp-derived THC products across the state. Championed by Lt. Gov. Dan Patrick, the measure criminalizes products containing any THC or THCA, despite opposition from 50% of voters, per a Texas Politics Project poll. The state's hemp industry, supporting 53,000 jobs and $268 million in tax revenue, now braces for litigation. Advocates are urging a veto.
Meanwhile, HB 46, aimed at expanding Texas' Compassionate Use Program, remains pending in the Senate. It proposes adding qualifying conditions like chronic pain, expanding licensing, and permitting more administration methods—but retains the 1% THC cap and bans flower.
DEA Report Criticizes Legal States, Admits Prohibition Fuels Illicit Trade
In its 2025 National Drug Threat Assessment, the DEA accused cartels of exploiting state-legal cannabis programs. However, the report also acknowledged that demand for illicit cannabis is driven largely by prohibition states—ironically making the case for federal reform.
DEA nominee Terrance Cole, in confirmation hearings, refused to take a position on rescheduling cannabis but called review of the issue a "first priority."
Read more on <a href="https://www.marijuanamoment.net/dea-blames-legal-marijuana-states-for-inadvertently-aiding-cartels-while-also-admitting-that-prohibition-states-create-illegal-market-opportunities">Marijuana Moment</a>
Argentina Overhauls REPROCANN Framework
The Ministry of Health issued Resolution 1780/2025, revamping Argentina's cannabis cultivation registry. Key changes include new rules for nonprofit growers, research institutions, and third-party cultivators, plus mandatory training and digital registration for prescribing doctors. While patients can retain current registrations for up to 3 years, others face stricter 1-year renewals and enhanced oversight.
Full breakdown via <a href="https://elplanteo.com/reprocann-cambios-2025">El Planteo</a>
<h3 class="wp-block-heading">Corporate &amp; M&amp;A</h3>
Blüm Holdings to Deepen Stake in Cookies
Blüm Holdings, Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/BLMH#OTCQB">BLMH</a>) signed a binding term sheet to acquire 100% of a holding company with an indirect equity stake in Cookies Creative Consulting &amp; Promotions, Inc. The transaction—worth roughly $562,500—could amplify Blüm's presence alongside one of cannabis's most recognized brands.
Village Farms Spins Off Fresh Produce Arm to Focus on Cannabis
Village Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) will transfer key greenhouse and distribution assets to a new private joint venture with Sweat Equities, dubbed Vanguard Food LP. The move unlocks $40 million in cash and refocuses the company's strategy on international cannabis.
<h3 class="wp-block-heading">Global Markets</h3>
Canada: Industry Pushes for Excise Tax Reform
Deloitte's 2025 report confirmed that Canada's cannabis excise tax model is crushing legal operators. The Cannabis Council of Canada renewed calls to replace the $1/gram floor with a 10% ad valorem tax, noting that current rules are outdated and misaligned with market prices.
GrowerIQ to Represent Canada on Thailand Trade Mission
Toronto-based GrowerIQ was selected by Global Affairs Canada to join a trade mission to Thailand, becoming the only cannabis company in the delegation. Thailand's market, legal since 2022, is expected to grow at a 33% CAGR over five years.
Tilray Launches &#8216;Good Supply&#8217; in Germany
Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) expanded its European medical cannabis footprint with Good Supply's launch in Germany. Strains include Snow Leopard, Purple Octane and Lemon Haze Gelato. Products will be available via prescription at German pharmacies.
Read more on <a href="https://www.benzinga.com/markets/cannabis/25/05/45573520/after-bankruptcy-and-a-lost-home-this-cannabis-team-rebuilt-from-the-ground-up-the-real-story-of-blimburn-seeds">Benzinga</a>
Curaleaf and TILT Secure EU Certification for Medical Inhaler
Curaleaf International, a subsidiary of Curaleaf (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) and TILT Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TLLTF#OTC">TLLTF</a>) announced EU Class IIa certification for their new handheld medical cannabis inhaler. The approval unlocks opportunities across the EU, UK, Canada, and Australasia.
<h3 class="wp-block-heading">Financials</h3>
Planet 13 Reports Q1 Revenue of $28M
Planet 13 Holdings (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PLNH#OTCQX">PLNH</a>) posted $28 million in Q1 2025 revenue—a 22.5% YoY increase. Gross margins shrank to 42.8%, while adjusted EBITDA swung to a $2.5 million loss. The company cited pressure on pricing and consumer demand.
Vext Grows Revenue 38%, Hits $3.1M in Operating Cash Flow
Vext Science (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VEXTF#OTCQX">VEXTF</a>) reported $11.6 million in Q1 revenue, up 38% YoY. Operating cash flow reached $3.1 million. The company highlighted growth in Ohio and retail resilience in Arizona.
<h3 class="wp-block-heading">Events &amp; Culture</h3>
#InvestInHER Returns to Benzinga Cannabis Capital Conference
Women-led groups like Women Grow, Verdant Strategies and IWC will host mentorship and networking events during the Benzinga Cannabis Capital Conference in Chicago (June 8–10). The #InvestInHER Lounge and scholarship programs aim to boost visibility, funding access, and leadership for women founders.
More info <a href="http://bzcannabis.com">here</a>
<h3 class="wp-block-heading">Recommended Reads Of The Week</h3>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/events/25/05/45526151/modelo-got-it-right-cannabis-didnt-says-latina-ceo-who-built-a-multi-state-business-with-10k">Modelo Got It Right, Cannabis Didn&#8217;t, Says Latina CEO Who Built A Multi-State Business With $10K</a></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/05/19/how-cannabis-drinks-are-reshaping-booze/">Weed In A Can: How Cannabis Drinks Are Changing The Ritual Of Drinking</a></li>
<li><a href="https://www.forbes.com/sites/javierhasse/2025/05/21/is-cannabis-justice-good-business-ben--jerrys-thinks-so/">Is Cannabis Justice Good Business? Ben &amp; Jerry's Thinks So</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/25/05/45573520/after-bankruptcy-and-a-lost-home-this-cannabis-team-rebuilt-from-the-ground-up-the-real-story-of-blimburn-seeds">After Bankruptcy And A Lost Home, This Cannabis Team Rebuilt From The Ground Up</a></li>
<li><a href="https://www.greenstate.com/lifestyle/premium-pot-products-newbie/">I gave a weed newbie some premium pot products—here's what he thought</a></li>
</ul>

Government

Politics

BLMH

PLNH

TLLTF

VEXTF

This Week In Cannabis: DEA Slams Legal Weed, Texas Votes Hemp Ban, Argentina Tightens Medical Rules And More

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 17.76% at $1.21</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 13.64% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 11.00% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 8.52% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 7.61% at $0.39</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 7.43% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 6.67% at $1.93</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed up 6.09% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 5.17% at $5.49</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 3.57% at $1.10</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 3.23% at $0.45</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MPXOF">MPX International</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPXOF#OTC">MPXOF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 98.29% at $0.00012</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 20.71% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 16.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 9.37% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 6.25% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 5.71% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 4.70% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.81% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed down 3.11% at $1.56</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBHPF

MPXOF

UGRO

Marijuana Stock Movers For May 22, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are trading higher on Thursday as the company unveiled a significant expansion of its medical cannabis footprint in Europe <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45561045/tilray-medical-brings-canadas-iconic-cannabis-brand-good-supply-to-germany" rel="noreferrer noopener">through its latest launch in Germany.</a>
Tilray Medical, the health-focused arm of the Canadian cannabis giant, announced it is bringing Good Supply, a brand known for affordable, high-quality cannabis flower, to the German market.
The move comes as the country&#8217;s medical cannabis sector evolves, with patients and providers seeking trusted therapeutic alternatives.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/05/45450937/the-30-billion-question-can-cannabis-pouches-do-what-zyn-did-for-nicotine" rel="noreferrer noopener">The $30 Billion Question: Can Cannabis Pouches Do What Zyn Did For Nicotine?</a>
Denise Faltischek, chief strategy officer and head of International at Tilray, stated, &#8220;With recent advancements in the medical cannabis industry, including enhanced formulations and broader availability, our goal remains steadfast—to provide patients in Germany with accessible, high-quality, and affordable medical cannabis solutions.&#8221;
Good Supply will offer multiple cultivars across Germany in both 15g and 500g formats, all available through prescription at pharmacies.
The Good Supply strains available in Germany include Snow Leopard (22% THC), Meringue 64 (25%), Purple Octane (22%), Ghost Gelato (25%), Lemon Haze Gelato (22%), Amnesia OG (22%), Space Age Cake (28%), and Skywalker Kush (18%).
With operations in Canada, Portugal, and Germany, Tilray Medical is reinforcing its leadership position in international medicinal cannabis markets.
In a separate <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45561974/introducing-yalls-beer-a-true-taste-of-texas-from-revolver-brewing" rel="noreferrer noopener">release</a>, Revolver Brewing, a North Texas craft beer brand under Tilray Brands, has launched a new lager called &#8216;Y&#8217;all&#8217;s Beer.&#8217;
Designed for everyday moments and shared experiences, it captures the spirit of togetherness and simple pleasures, the company said.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 76% in the past year. Investors can gain exposure to the stock via AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Price Action: TLRY shares are trading higher by 3.5% to $0.45 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/events/25/05/45526151/modelo-got-it-right-cannabis-didnt-says-latina-ceo-who-built-a-multi-state-business-with-10k" target="_blank" rel="noreferrer noopener">Modelo Got It Right, Cannabis Didn&#8217;t, Says Latina CEO Who Built A Multi-State Business With $10K</a></li>
</ul>
Photo: VladyslaV Travel photo/ Shutterstock

Equities

YOLO

What's Going On With Tilray Brands Stock On Thursday?

<a href="https://www.marijuanamoment.net/senate-committee-approves-trumps-dea-pick-who-has-refused-to-say-if-he-supports-marijuana-rescheduling-proposal-before-agency/" title="https://www.marijuanamoment.net/senate-committee-approves-trumps-dea-pick-who-has-refused-to-say-if-he-supports-marijuana-rescheduling-proposal-before-agency/">https://www.marijuanamoment.net/senate-committee-approves-trumps-dea-pick-who-has-refused-to-say-if-he-supports-marijuana-rescheduling-proposal-before-agency/</a>

'Senate Committee Approves Trump's DEA Pick Who Has Refused To Say If He Supports Marijuana Rescheduling Proposal Before Agency' - Marijuana Moment

Tilray Medical Announce The Launch Of Good Supply In Germany

<a href="https://x.com/MarijuanaMoment/status/1925220244504621454" title="https://x.com/MarijuanaMoment/status/1925220244504621454">https://x.com/MarijuanaMoment/status/1925220244504621454</a>

"Marijuana Rescheduling Blocked By Opposition 'From Within' DEA, Biden's Drug Czar Says" - Marijuana Moment

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 25.85% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 23.48% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 18.75% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 17.65% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 12.50% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 10.03% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 9.69% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 8.33% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 8.16% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 5.72% at $7.76</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 4.21% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 4.18% at $0.71</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 4.01% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 3.60% at $0.40</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 3.41% at $4.45</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 14.71% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 9.49% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 8.39% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 8.38% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 5.96% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed down 4.19% at $2.06</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 4.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed down 3.68% at $1.31</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 3.23% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBRRF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

LMLLF

Cannabis Stock Gainers And Losers From May 19, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed up 6900.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 70.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 20.90% at $1.66</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 11.20% at $0.49</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 9.43% at $1.04</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 6.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 5.77% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 5.55% at $7.34</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 4.39% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 3.53% at $0.38</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.44% at $5.13</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 11.11% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 10.89% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 9.38% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 7.63% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 6.59% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 5.66% at $0.83</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 5.36% at $0.68</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.33% at $4.46</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 4.04% at $0.95</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KAYS

Cannabis Stock Movers For May 16, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are trading relatively flat in <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">the premarket session on Wednesday</a>.
The firm has announced a product line expansion through its subsidiary, High Park Holdings Ltd., entering deeper into <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45402188/tilray-brands-announces-the-launch-of-xmg-atomic-sours-new-thc-beverages-and-edibles" rel="noreferrer noopener">Canada's cannabis-infused consumer market.</a>
The launch of XMG Atomic Sours, a new lineup of sour-flavored cannabis drinks and gummies, is the latest move in Tilray's bid to diversify its product portfolio and tap into emerging customer preferences.
Tilray said that the XMG Atomic Sours beverages is available nationwide via select retailers.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-e500m-2500-pharmacies-now-dispense-211-grow-clubs-approved" rel="noreferrer noopener">Germany&#8217;s Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved</a>
It includes the flavors Cherry Blasted Lime and Foggy Peaches. Each 355ml drink includes 10mg of THC, 10mg of CBG, and a caffeine content of 30mg sourced from guarana extract.
According to the company, the beverages utilize nano-emulsified THCA diamonds to speed up onset time, aligning with demand for fast-acting cannabis products.
The XMG Atomic Sours Gummies represent High Park's entry into the cannabis edibles space.
Plant-based pectin is used in place of gelatin, and the gummies are shaped like keys—a nostalgic nod aimed at invoking flavor memories. The company describes the flavor experience as "intensely sour."
This apart, the company continues to grow its cannabis and beverage offerings in North America and recently saw the return of its Blue Point Brewing Co. Delayed Pilsner—targeted at the New York commuting crowd—<a target="_blank" href="https://www.benzinga.com/25/05/45233132/whats-going-on-with-tilray-brands-stock-on-tuesday]" rel="noreferrer noopener">back on shelves earlier this month</a>.
The brand expansion aligns with Tilray's long-term strategy to compete across multiple cannabis consumption categories.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 78% in the past year. Investors can gain exposure to the stock via AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Price Action: TLRY shares are trading higher by 0.09% to $0.4508 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp" target="_blank" rel="noreferrer noopener">Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</a></li>
</ul>
Photo: Shutterstock

What's Going On With Tilray Brands Stock On Wednesday?

Tilray Subsidiary High Park Launches XMG Atomic Sours Line Of Cannabis Beverages And Gummies With 'Nostalgic Sour Flavours'

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FLOOF">Flower One Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLOOF#OTC">FLOOF</a>) shares closed up 9900.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 17.65% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 13.05% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 9.92% at $1.46</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 9.92% at $7.16</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 8.46% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 7.69% at $1.12</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 7.50% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 6.25% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 5.69% at $1.07</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 5.58% at $57.00</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed up 5.22% at $0.70</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 4.33% at $5.06</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 4.24% at $1.28</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.38% at $1.52</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ALEAF">Aleafia Health</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALEAF#OTC">ALEAF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/BMMJ">Body and Mind</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) shares closed down 98.72% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 46.90% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 24.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 20.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 16.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 15.07% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 10.81% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 10.53% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 9.09% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 7.43% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 7.18% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 7.07% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 4.31% at $9.54</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 4.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 3.33% at $0.08</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

CPHRF

FLOOF

Marijuana Stock Movers For May 12, 2025

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 85.25% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 37.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 25.00% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 25.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 25.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 24.44% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 16.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 14.95% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 9.45% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 8.36% at $0.24</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 8.02% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 7.73% at $0.04</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNGGF">Cann Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNGGF#OTC">CNGGF</a>) shares closed down 65.46% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 23.08% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 22.41% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 16.00% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.04% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 13.01% at $1.04</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 11.53% at $0.73</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 10.76% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed down 9.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 7.14% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 6.21% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 5.44% at $9.97</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 4.97% at $5.54</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 4.41% at $0.41</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 4.13% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 3.75% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.46% at $0.43</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.40% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.01% at $6.45</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLGVF

Marijuana Stock Movers For May 9, 2025

Germany's <a href="https://www.benzinga.com/topic/germany-cannabis">cannabis landscape</a> continues evolving at a rapid pace. From extensive pharmacy access to a surge in cultivation associations, the country's dual-track model—medical and non-commercial adult use—has turned it into one of the most closely watched cannabis markets in the world.
Still, many in the industry argue that restrictive EU regulations are preventing Germany from reaching its full potential.
<h3 class="wp-block-heading">1 In 7 Pharmacies Now Dispenses Medical Cannabis</h3>
As reported by <a href="https://internationalcbc.com/more-than-1-out-of-every-7-german-pharmacies-offers-medical-cannabis/?utm_source=ICBC+Combined+List+Newsletter+and+Outreach&amp;utm_campaign=7599cd320e-EMAIL_CAMPAIGN_2025_05_05_06_44&amp;utm_medium=email&amp;utm_term=0_-7599cd320e-23726375">ICBC</a>, roughly 2,500 of Germany's 17,000 pharmacies now offer medical cannabis products—a dramatic expansion since legal access began in 2017. Patients can also order cannabis online with a private prescription and have it delivered directly to their homes.
According to the German Cannabis Business Association (BvCW), the country's legal medical cannabis revenue is now estimated at around half a billion euros annually.
Yet that number only scratches the surface of the market's potential. At ICBC Berlin, economist Beau Whitney presented data showing flower and extract sales dominate the German market due to a ban on edibles and other product formats. For comparison, U.S. 4/20 sales were only 41% flower, with the rest divided between vapes, <a href="https://www.benzinga.com/markets/cannabis/25/05/45263739/they-turned-fruit-bouquets-into-a-500m-a-year-businessnow-theyre-selling-thc-heres-why">edibles</a>, <a href="https://www.benzinga.com/markets/cannabis/25/04/44929611/why-pre-rolls-are-cannabis-most-profitable-format-from-california-to-canada">pre-rolls</a> and topicals.
The takeaway? Consumers who prefer smokeless options have limited legal choices in Germany, leaving the door open for the unregulated market.
<h3 class="wp-block-heading">Germany's Cultivation Associations Are Growing Fast</h3>
Meanwhile, the number of licensed cannabis cultivation associations continues to rise. As of early May, Germany had approved 211 of the 624 applications submitted nationwide since the member-based model went live in July 2024.
The associations—legal under EU health policy frameworks—allow registered members to collectively grow cannabis for personal use. Though not commercial in nature, they offer a legal alternative for adults seeking safe, regulated cannabis outside the pharmacy system.
For perspective, Malta—another EU member state with a similar model—has issued 19 permits for its 570,000 residents. Applying Malta's ratio to Germany's population of 84 million implies that over 2,800 associations could eventually be formed.
Still, much remains in flux. Only 25 German applications have been formally rejected so far and many approved groups are still navigating the setup phase.
<h3 class="wp-block-heading">What's Next?</h3>
Germany is already Europe's largest cannabis market, and interest from international operators and policymakers shows no sign of slowing. But experts say broader legalization—including more product categories and commercial access—is essential to meet patient demand and curb illicit activity.
As the BvCW notes, &#8220;the industry's revenue is now estimated at around half a billion euros"—but with edibles, national retail and broader exports still off-limits, the true ceiling remains far higher.
<h3 class="wp-block-heading">Stocks To Watch</h3>
Germany's expanding cannabis market has attracted significant investment from major publicly traded companies. Here are some key players:
<ul>
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>): Tilray operates a GMP-certified cultivation facility in Neumünster and has recently expanded its medical cannabis offerings in Germany, including new extract formulations and high-THC flower strains under the Tilray Craft brand.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): Aurora launched its first domestically grown medical cannabis brand, IndiMed, cultivated at its EU-GMP facility in Leuna. This move positions Aurora as one of the few companies with local production capabilities in Germany.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): Canopy Growth has introduced its Tweed brand to the German medical cannabis market, expanding its product lineup with new strains through strategic partnerships with EU-based cultivators.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): Curaleaf has taken a majority stake in Germany&#8217;s Four 20 Pharma, enhancing its footprint in the European market and aiming to leverage Four 20 Pharma&#8217;s distribution network.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>): High Tide initially planned to enter the German medical cannabis market through the acquisition of Purecan GmbH. However, the company is currently reevaluating this strategy and exploring alternative arrangements to establish a presence in Germany.</li>
</ul>
Photo: Shutterstock

HITI

Germany's Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 21.95% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 18.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.40% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 6.26% at $1.10</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.89% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 4.88% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.89% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.41% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 3.33% at $0.06</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 28.86% at $0.13</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 18.03% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 11.59% at $6.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 11.11% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 9.01% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 7.91% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 6.70% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 6.33% at $0.87</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 5.76% at $6.05</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.91% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.69% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.55% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.29% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.28% at $4.47</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.94% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 3.86% at $0.86</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.66% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 3.45% at $1.12</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 3.16% at $53.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IIPR

Cannabis Stock Gainers And Losers From May 6, 2025

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) moved lower on Tuesday following the launch of a timely and tongue-in-cheek offering <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45216984/blue-point-brewing-co-announces-the-return-of-delayed-pilsner" rel="noreferrer noopener">from one of its subsidiaries.</a>
Blue Point Brewing Co., a well-known craft beer brand under Tilray&#8217;s beverage umbrella, has announced the return of its Delayed Pilsner — a brew created with New York commuters in mind.
The lager, originally developed as a nod to the all-too-frequent public transportation delays in the city, is once again hitting shelves across the Metro New York area.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp" rel="noreferrer noopener">Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</a>
Carrie Shafir, senior brand director at Tilray Beverages, shared the intention behind the product: &#8220;Delayed Pilsner is our way of helping New Yorkers find a moment of peace amidst the chaos. It&#8217;s a beer that&#8217;s not just refreshing but also comforting.&#8221;
The 16-ounce can features a design inspired by the familiar &#8220;delayed&#8221; signage seen on Penn Station&#8217;s departure boards, particularly referencing Long Island destinations.
It&#8217;s a visual cue that blends humor with an all-too-relatable experience for city residents.
Delayed Pilsner is available in 16oz cans at select retailers and major transit centers across New York.
Tilary Beverages recently launched a new whiskey expression <a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">under its acclaimed&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">Breckenridge Distillery</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">&nbsp;brand.</a>
The distillery unveiled the latest addition to its cask-finished lineup: Breckenridge Cognac Cask Finish Whiskey, which is available in Colorado with broader U.S. distribution anticipated later this year.
Originally released in 2022 as part of the second Collectors Art Series, this limited edition whiskey has returned with an elevated production run.
Price Action: TLRY shares are trading lower by 3.78% to $0.4229 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45229767/pltr-focused-etfs-down-whats-really-behind-palantirs-plunge-the-numbers-dont-tell-the-full-story" target="_blank" rel="noreferrer noopener">PLTR-Focused ETFs Down: What&#8217;s Really Behind Palantir&#8217;s Plunge? The Numbers Don&#8217;t Tell The Full Story</a></li>
</ul>
Photo: Shutterstock

What's Going On With Tilray Brands Stock On Tuesday?

Restaurants

Press Releases

Widmer Brothers Brewing Celebrates 40th Anniversary

10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

Blue Point Brewing Co. Announces the Return of Delayed Pilsner

Shock Top: A Bold Rebrand for a Craft Beer Icon

Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles

Small Cap

Opinion

The $600B Beverage Shift: Why Function Is Outpacing Flavor

Tilray Medical Brings Canada's Iconic Cannabis Brand Good Supply to Germany

Introducing Y'all's Beer: A True Taste of Texas from Revolver Brewing

Tilray Brands to Present at TD Cowen's 9th Annual Future of the Consumer Conference

SweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition Beer

COCO

HAIN

SHOT

TSX:TLRY

ZVIA

Alumis

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Evolus

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

GH Research

Maze Therapeutics

MBX Biosciences

Nuvation Bio

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

SIGA Technologies

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Trevi Therapeutics

Tvardi Therapeutics

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings

Zevra Therapeutics

Zhengye Biotechnology Holding Limited - Ordinary Shares

Zhengye Biotechnology

Piper Sandler

Roth MKM

CIBC

TD Cowen

Alliance Global Partners

메타 플랫폼스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)는 케임브리지 애널리티카(Cambridge Analytica)의 데이터 스캔들에 대한 미국 대법원의 <a href="https://www.benzinga.com/general/social-media/24/06/39259832/metas-legal-battle-over-cambridge-analytica-scandal-heads-to-supreme-court" target="_blank" rel="noopener" data-google-interstitial="false">항소가 기각</a>된 후 수십억 달러 규모의 소송에 직면할 예정이다.
무슨 일이 있었나: 대법원은 11월 6일 메타의 항소에 대한 변론을 듣고 이 기각 이유를 설명하지 않았다.
해당 사건이 &#8216;즉흥적으로 승인된 것으로 기각&#8217;되었다고 블룸버그가 <a href="https://www.bloomberg.com/news/articles/2024-11-22/facebook-appeal-over-shareholder-suit-dropped-by-supreme-court?srnd=phx-technology" target="_blank" rel="noopener">보도</a>했다.
이번 기각으로 인해 마크 저커버그의 메타가 잠재적으로 최대 20억 달러에 달하는 값비싼 합의에 직면할 가능성이 높아졌다고 블룸버그 인텔리전스의 분석가 매튜 셰튼헬름(Matthew Schettenhelm)이 추정했다.
메타는 성명서에서 실망감을 표하며 원고의 주장은 근거가 없다고 주장했다. &#8220;사건이 지방 법원에서 고려되는 동안 우리는 계속 방어할 것이다.&#8221;
참고: <a href="https://www.benzinga.com/24/11/42053396/why-chinese-tech-giants-alibaba-bytedance-and-meituan-are-expanding-their-ai-footprints-in-silicon-valley-amid-us-efforts-to-block-progress?itm_source=parsely-api">중국의 기술 거대 기업인 알리바바, 바이트댄스, 그리고 메이투안이 실리콘밸리 AI 입지를 확장하는 이유</a>
메타는 2018년 케임브리지 애널리티카 스캔들과 관련하여 주주들에게 개인 데이터 3,000만 명 이상의 사용자 정보가 무단으로 사용된 위험에 대해 잘못된 정보를 제공한 혐의를 받고 있다.
주주들은 해당 데이터 유출 사실이 결국 2018년에 두 차례의 주가 하락을 초래하여 회사의 시장 가치가 2,000억 달러 이상 감소했다고 주장하고 있다.
메타는 <a href="https://pro.benzinga.com/dashboard">벤징가의</a> 성명 요청에 즉각 응답하지 않았다.
중요한 이유: 메타는 지난 10월 미국 지방 판사가 미국 주들에서 제기된 두 건의 소송 청구를 기각하려는 회사의 시도를 기각하면서 또 다른 법적 어려움에 직면했다.
이 소송들은 <a href="https://www.benzinga.com/news/24/10/41349398/mark-zuckerbergs-meta-to-face-lawsuits-over-teen-social-media-addiction-judge-rejects-dismissal-moti">메타가 플랫폼을 중독성 있게 만들어</a> 청소년의 정신 건강 문제에 영향을 미쳤다고 비난했다.
또한 주주 소송은 기술 산업에서 일반적인 현상이다. 예를 들어, 10월에 알리바바 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)은 <a href="https://www.benzinga.com/markets/equities/24/10/41559403/alibaba-agrees-to-433-5m-settlement-in-shareholder-class-action-lawsuit" target="_blank" rel="noopener" data-google-interstitial="false">주주들이 제기한 집단 소송</a>에서 4억 3,350만 달러의 합의에 동의했다.
마찬가지로 틸레이 브랜즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>)는 회사의 잘못된 투표 관행을 고발하는 <a href="https://www.benzinga.com/news/legal/24/11/42015978/shareholder-lawsuit-challenges-tilrays-voting-tactics-for-authorized-share-increase" target="_blank" rel="noopener" data-google-interstitial="false">주주 소송에 직면</a>했다.
현재 대법원은 <a href="https://www.benzinga.com/news/legal/24/11/41960485/nvidias-crypto-past-returns-to-haunt-as-supreme-court-signals-green-light-for-lawsuit" target="_blank" rel="noopener">엔비디아</a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)의 항소도 검토 중입니다. 이 소송은 회사가 시장 붕괴 이전에 암호화폐 채굴 매출에 대한 의존성을 <a href="https://www.benzinga.com/news/legal/24/11/41960485/nvidias-crypto-past-returns-to-haunt-as-supreme-court-signals-green-light-for-lawsuit">주주들에게 잘못 알렸다는</a> 주장을 포함하고 있다.
주가 동향: 메타의 주가는 금요일에 0.7% 하락하여 주가는 559.14달러로 마감했다. 애프터 마켓에서 주가는 0.098% 상승하여 559.69달러에 거래되었다.
다음으로 읽어야 할 것:
<ul>
<li><a href="https://www.benzinga.com/24/11/42132292/mark-zuckerbergs-meta-takes-on-64b-pig-butchering-scams-targeting-people-through-dating-apps-social-media-crypto-investing-and-other-apps">마크 저커버그의 메타가 데이트 앱, 소셜 미디어 및 암호화폐 투자와 관련된 640억 달러 규모의 &#8216;돼지 도살&#8217; 사기를 단속</a></li>
</ul>
사진 제공: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

틸레이 브랜즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>)는 월요일 시장 마감 후 2024 회계연도 4분기 재무 결과를 발표했다. 이번 분기의 <a href="https://www.benzinga.com/pressreleases/24/07/g40021997/tilray-brands-reports-record-financial-results-achieves-26-net-revenue-growth">주요 지표</a>를 살펴보세요.
4분기 실적: 틸레이는 회계연도 4분기 매출이 2억 2,988만 2천 달러로 전년 대비 약 25% 증가했다고 보고했다. <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>의 데이터에 따르면 회사의 최고 실적은 <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">컨센서스 추정치</a>인 2억 2,707만 달러를 초과했다.
해당 분기에 대마류 제품의 순매출은 12% 증가한 7,190만 달러를 기록했으며, 음료-주류 순매출은 137% 증가한 7,670만 달러를 기록했다. 4분기 유통 순매출은 6,560만 달러로 감소했다. 웰니스 순매출은 6% 증가한 1,570만 달러를 기록했다.
틸레이는 4분기 조정 이익을 주당 4센트로 보고했는데, 이는 주당 2센트 손실에 대한 예상치를 뛰어넘는 수치이다. 4분기 총 이익은 8,240만 달러였다. 총 마진 및 조정 총 마진은 36%였다. 4분기 조정 EBITDA는 전년 동기 대비 37% 증가한 2,950만 달러를 기록했다. 틸레이는 2024 회계연도에 순전환사채를 약 3억 달러 줄였다고 밝혔다.
틸레이 브랜즈의 회장 겸 CEO인 어윈 사이먼(Irwin Simon)은 &#8220;틸레이 브랜즈는 전 세계적으로 대마초, 음료 및 웰빙의 융합을 선도하고 있다&#8221;고 말했다.
"2024 회계연도에 회사는 전년 대비 순매출 26% 증가, 총 이익 및 조정 EBITDA 부문에서 기록적인 성과를 거두고 회계연도에 플러스 조정 잉여 현금 흐름을 창출하는 등 사업 전반에 걸쳐 눈에 띄는 성장을 달성했다. 또한 순전환사채를 최대 3억 달러까지 크게 줄이고 비용 절감 시너지 목표를 초과하여 대차대조표를 강화했다.&#8221;
TLRY 주가 움직임: 월요일 <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">틸레이</a>의 주식은 시간외 거래에서 10.38% 상승한 2.02달러를 기록했다.
This illustration was generated using artificial intelligence via Midjourney.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Tilray Brands

뉴스

에 대한 최신 뉴스 Tilray Brands (NASDAQ:TLRY) 주식

토요일, 11월 23, 2024

월요일, 7월 29, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌